Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene.
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Hsu
H
Wu
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jin-Yuan
JY
Shih
Graduate Institute of Oncology, National Taiwan University and, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: chihyang@ntu.edu.tw.
James Chih-Hsin
JC
Yang
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics; D000077192:Adenocarcinoma of Lung; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics* / Q000378:metabolism*; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*; D000077210:Sunitinib
D000970:Antineoplastic Agents; D007211:Indoles; C573239:KIF5B-RET fusion protein, human; D015514:Oncogene Proteins, Fusion; D011758:Pyrroles; D000077210:Sunitinib